Literature DB >> 20434041

Resection of primary sternal osteosarcoma and reconstruction with homologous iliac bone: case report.

Peng Ren1, Jianguo Zhang, Xizeng Zhang.   

Abstract

Primary sternal osteosarcoma is rare and has a poor prognosis. Here, we describe the case of a 44-year-old man with sternal osteosarcoma. He underwent subtotal sternectomy with partial resection of the bilateral ribs and left clavicle. Sternal reconstruction was performed with an iliac bone allograft, which was fixed by polyester suture. The patient had a normal postoperative course, followed by adjuvant chemotherapy. The allograft healed with correct integration, and have been no signs of recurrence and absorption during 14 years of follow-up. The homologous iliac bone is a good choice for sternal reconstruction because it can become a part of the host. (c) 2010 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20434041     DOI: 10.1016/S0929-6646(10)60057-5

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

1.  Primary Osteosarcoma of the Sternum: A case Report and Review of the Literature.

Authors:  Masoud Pezeshki Rad; Seyd Hosein Fattahi Masoum; Parvaneh Layegh; Mohsen Salari Rad
Journal:  Arch Bone Jt Surg       Date:  2014-10-15

2.  Sternal Tumor Resection and Reconstruction Using Iliac Crest Autograft.

Authors:  Kyle D Drinnon; Samir Sherali; Cameron T Cox; Brendan J MacKay
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-08-18

3.  Recurrent radiation-induced osteosarcoma of the sternum in a patient with remote radiation therapy for breast cancer.

Authors:  Joseph M Limback; Haley P Letter; Kurt F Scherer; Christopher W Wasyliw; Laura W Bancroft
Journal:  Radiol Case Rep       Date:  2016-07-12

4.  Autologous ilium graft combination with Y-shaped titanium plate fixation for chest wall reconstruction after resection of primary sternal tumors-a clinical study from three institutions.

Authors:  Shuonan Xu; Yawei Dou; Guolong Zhao; Jianfei Zhu; Wei Tian; Wei Sun; Zongzhi Liu; Lanjun Zhang; Hongtao Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.